Vistagen Therapeutics Inc
For the period ended Mar 31, 2025. Filed Jun 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 17, 2025
VTGN$0.18+12.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to our 2025 Annual Meeting of Stockholders, which we will file with the SEC on or before July 29, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.